Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy

Diabetes

Volumn 39, Issue 8, 1990, Pages 983-988

  Iwashima, Yasunori ^a   Sato, Takao ^b   Watanabe, Kiyoshi ^b   Ooshima, Eiji ^b   Hiraishi, Sayuri ^b   Ishii, Hidemi ^b   Kazama, Mutsuyoshi ^b   Makino, Isao ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MARKER; MEMBRANE PROTEIN; THROMBOMODULIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; AGED; ALBUMINURIA; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CREATINE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN; MALE; MIDDLE AGE; RECEPTORS, CELL SURFACE; RECEPTORS, THROMBIN;

EID: 0025371576     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.39.8.983     Document Type: Article

References (51)

1. Esmon CT, Owen WG: Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78:2249-52, 1981
2. Esmon NL, Owen WG, Esmon CT: Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257:859-64, 1982
3. Salem HH, Maruyama I, Ishii H, Majerus PW: Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 259:12246-51, 1984
4. Walker FJ, Sexton PW, Esmon CT: The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 571:333-42, 1979
5. Vehar GA, Davie EW: Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 19:401-409, 1980
6. Marlar, RA, Kleiss AJ, Griffin JH: Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 59: 1067-72, 1982
7. Suzuki K, Stenflo J, Dahlback B, Teodorsson G: Inactivation of human coagulation factor V by activated protein C. J Biol Chem 258:1914-20, 1983
8. Esmon CT, Esmon NL, Harris KW: Complex formation between thrombin and thrornbomodulin inhibits both thrombin catalyzed fibrin formation and factor V activation. J Biol Chem 257:7944-47, 1982
9. Esmon NL, Carroll RC, Esmon CT: Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 258:12238-42, 1983
10. Maruyama I, Salem HH, Ishii H, Majerus PW: Human thrombomodulin is not efficient inhibitor of the procoagulant activity of thrombin. J Clin Invest 75:987-91, 1985
11. a-mediated cleavage of prothrombin. J Clin Invest 78:13-17, 1986
12. Ishii H, Majerus PW: Thrombomodulin is present in human plasma and urine. J Clin Invest 76:2178-81, 1985
13. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-32, 1982
14. Parving H-H, Oxenboll B, Svendsen PA, Christiansen JS, Anderson AR: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol 100:550-55, 1982
15. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
16. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-60, 1984
17. Jarret RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1:17-19, 1984
18. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington diabetic survey. Lancet 1:530-33, 1988
19. Rose GA, Blackburn H: Cardiovascular Survey Methods. Geneva, World Health Org., 1968 (Monogr. no. 56)
20. Cole RA, Soeldner JS, Dunn PJ, Bunn HF: A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism 27:289-301, 1978
21. Husdan H, Rapoport A: Estimation of creatinine by the Jaffé reaction. Clin Chem 14:222-38, 1968
22. Ishii H, Nakano M, Tsubouchi J, Ishikawa T, Uchiyama H, Hiraishi S, Tahara C, Miyajima Y, Kazama M: Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemostasis 63:157-62, 1990
23. Feldt-Rasmussen B, Dinesen B, Decker M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-44, 1985
24. Shaw AB, Risdon P, Lewis-Jackson J: Protein creatinine index and albustix in assessment of proteinuria Br Med J 287:929-32, 1983
25. Fornasari PM, Gamba G, Dolchi D, Gratton L, Ascari E: Circadian rhythms in fibrinolysis. In Haemostasis and Thrombosis: Thrombosis. Serneri N, Prentice CRM, Eds. London, Academic, 1979, p. 773-77 (Serono Symp. 15)
26. Cepelak V, Barcal R, Cepelakova H, Mayer O: Circadian rhythm of fibrinolysis. In Progress in Chemical Fibrinolysis and Thrombosis. Davidson JF, Rowan R, Eds. New York, Raven, 1978, p. 571-78
27. Kluft C, Jie AFH, Rijken J, Verheijen JH: Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemostasis 59:329-32, 1988
28. Feldt-Rasmussen B: Increased transcapillary escape rate of albumin in type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetalogia 29:282-86, 1986
29. Kennedy L, Baynes JW: Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia 26:93-98, 1984
30. Cogan DG, Kinoshita JH, Kador PF, Robinson WG, Datilis MB, Cobo LM, Kupfer C: Aldose reductase and complications of diabetes. Ann Intern Wed 101:82-91, 1984
31. Mcmillan DE: The effect of diabetes on blood flow properties. Diabetes 32 (Suppl. 2):56-63, 1983
32. Deckert T, Feldt-Rasmussen B, Borch-Johsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis, Diabetologia 32:219-26, 1989
33. Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M: Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med 300:366-67, 1979
34. Dollery CT, Friedman LA, Hensby CN, Kohner E, Lewis PJ, Porta M, Webster J: Circulating prostacyclin may be reduced in diabetes. Lancet 2:1365, 1979
35. 2 by diabetic platelets Eur J Clin Invest 9:223-28, 1979
36. Halushka PV, Rogers RC, Loadholt CB, Colwell JA: Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87-96, 1981
37. Heath H, Brigden WD, Canever JW, Pollock J, Hunter PR, Kelsey J, Bloom A: Platelet adhesives and aggregation in relation to diabetic retinopathy. Diabetologia 7:308-15, 1971
38. Kwaan HC, Colwell J, Cruz S, Suwanwela N, Dobbie JG: Increased platelet aggregation in diabetes mellitus, J Lab Clin Med 80:236-46, 1972
39. Ceriello A, Dello Russo P, Zuccotti C, Florio A, Nazzaro S, Pietrantuono C, Rosato GB: Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation: a preliminary report. Thromb Haemostasis 50:633-34, 1983
40. Brownlee M, Vlassara H, Cerami A: Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation: possible role in fibrin deposition in diabetes. Diabetes 33:532-35, 1984
41. Maruyama I, Bell CE, Majerus PW: Thrombomodulin is found on endothelium of arteries, veins, capillaries and lymphatics and syncytiotrophoblast of human placenta. J Cell Biol 101:363-71, 1985
42. Uehara F, Maruyama I, Unoki K, Yonezawa S, Igata A, Ohba N: Thrombomodulin in the eye: immunohistochemical identification. New Ophthalmol 3:1197-99, 1986
43. Ross R: The pathogenesis of atherosclerosis: an update. N Engl J Med 314:488-500, 1986
44. Boneu B, Abbal M, Plante J, Bierne R: Factor-VIII complex and endothelial cell damage. Lancet 1:1430, 1975
45. Porta M, Townsend C, Clover GM: Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 20:597-601, 1981
46. Bensousson D, Levy-Toiledano S, Passa P, Caen J, Canivet J: Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia 11:307-12, 1975
47. Jensen T: Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. Br Med J 298:27-28, 1989
48. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1:461-63, 1989
49. Hoyer LW, de los Santos RP, Hoyer JP: Anti-hemophilic factor antigen: localization in endothelial cells by immunofluorescent microscopy. J Clin Invest 52:2737-44, 1973
50. Howard MA, Montgomery DC, Hardisty RM: Factor VIII-related antigen in platelets Thromb Res 4:617-24, 1974
51. Porta M, Maneschi F, White MC, Kohner EM: Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy. Metabolism 30:695-99, 1981